Navigation Links
Covaris Receives the Society for Laboratory Automation and Screening (SLAS) New Product Award at LabAutomation 2011
Date:2/9/2011

WOBURN, Mass., Feb. 9, 2011 /PRNewswire/ -- The Covaris® LE220™ high performance ultra-sonicator has received the prestigious SLAS New Product Award at the LabAutomation 2011 conference in Palm Springs CA.  With over 4,400 attendees, LabAuto is the premier laboratory automation conference and exhibition, bringing science, technology, and industry together.

Breakthrough products introduced at LabAutomation are evaluated by a team of industry experts.  Each year, the best and most promising new products are recognized with the SLAS New Product Award.  Covaris is very pleased to announce that for 2011, the LE220 is a recipient of the New Product Award designation.  

The LE220 was chosen for the New Product Award from more than 400 LabAutomation 2011 exhibitors, based on its technical originality, anticipated impact on the field of laboratory automation, supporting data that reflects universal scientific methodology, and market demand.  According to Jim Laugharn, Founder and CEO, "The NPA award is significant recognition and is an affirmation that the patented, controlled AFA physicochemical process is indeed a unique technology platform.  This award also reflects the increasing importance of sample preparation as a fundamental component of advanced life science systems, such as in Next Generation DNA Sequencing."

The LE220 Ultra-sonicator

The LE220 is specifically designed for high-throughput, parallel-processing operations utilizing the Covaris Adaptive Focused Acoustic™ (AFA™) technology.  The LE220 is ideal for next-gen nucleic acid sequencing, compound dissolution, tissue/cell lysis applications, and other high-throughput applications.  With DNA shearing performance characteristics matching industry-standard Covaris S-series and E-series instruments, the LE220 reproducibly shears DNA to desired lengths, in a multi-sample parallel-processing mode.  The LE220 is designed to improve sample processing throughput 8 fold over single sample methods in a 96 tube format (32 fold in a 384 well format).

About Covaris, Inc.

Covaris, Inc. provides advanced sample preparation systems for life and analytical science.  Our sample prep technologies support a wide variety of applications including next-generation DNA sequencing, ChIP, proteomics, and compound management.  Our patented Adaptive Focused Acoustic (AFA) technology enables a high energy density to bring unsurpassed speed and efficiency to biological and chemical sample preparation.  The AFA process, based on shock wave physics, delivers controlled, precise, and accurate energy to biological and chemical samples

Information about Covaris is available at http://www.covarisinc.com.

About SLAS

Founded in 1996, SLAS is a worldwide organization providing leadership and educational benefits on the utilization of automation technologies, robotics, and artificial intelligence in order to improve the quality, efficiency, and relevance of laboratory analysis within and across multiple industries.  Laboratory Automation includes podium presentations, poster sessions, and exhibiting companies from all over the world showcasing the latest in laboratory automation technologies.  

Information about SLAS is available at http://www.slas.org.


'/>"/>
SOURCE Covaris, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
5. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
6. CryoCor Receives FDA Approval for Right Atrial Flutter
7. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
8. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
9. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
10. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
11. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)...  Eli Lilly and Company (NYSE: LLY ... EXPEDITION3 trial at the 9 th Clinical Trials ... did not meet the primary endpoint in the EXPEDITION3 ... with mild dementia due to Alzheimer,s disease (AD), and ... the treatment of mild dementia due to AD. ...
(Date:12/8/2016)... QUEBEC CITY , Dec. 8, 2016 /PRNewswire/ ... key US patents for improving the accuracy, reproducibility ... CD images in long and small bone orthopaedic ... proprietary approach to creating personalized orthopaedic restorations based ... create personalized orthopaedic restorations, the company harnesses the ...
(Date:12/8/2016)... , Dec. 8, 2016  EIP Pharma, ... has obtained proof-of-mechanism for neflamapimod (previously code named ... Phase 2a clinical trials that demonstrated significant Alzheimer,s ... 302 (12-week treatment) and Study 303 (6-week treatment) ... Trials in Alzheimer,s Disease (CTAD) scientific conference in ...
Breaking Medicine Technology:
(Date:12/10/2016)... ... December 10, 2016 , ... The ... PATS recently joined forces with other healthcare organizations to promote diabetes education at ... in Harrisburg, featured a variety of speakers from around the Commonwealth of Pennsylvania. ...
(Date:12/9/2016)... , ... December 09, 2016 , ... ... and aural rehabilitation—provided by audiologists—to remain a critical part of public access to ... Drug Administration (FDA) announced this week that, starting immediately, it would ...
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... ... miniature, folded, pharmaceutical inserts and outserts. As a means of expanding capabilities ... addition will enable Flottman to individually code professional inserts (PIs) and patient package ...
(Date:12/9/2016)... ... December 09, 2016 , ... ... its 10th anniversary with the grand opening of the Sober College Robert Pfeifer ... spanned two days, December 2-3, and was attended by an overwhelming amount of ...
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... ... Ball at The Pierre Hotel in New York, NY, on December 3rd, to ... dignitaries and physicians attended the annual event, which raised over $1 million - ...
Breaking Medicine News(10 mins):